Vogenx (VOGX) vs Zentalis Pharmaceuticals (ZNTL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Vogenx is the larger company by market cap ($260.9 million vs $259.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | VOGX | ZNTL |
|---|---|---|
| Share price | $17.56 | $2.64 |
| Market cap | $260.86M | $259.04M |
| 1-day change | +0.40% | +5.18% |
| YTD return | — | +95.56% |
| 1-year return | — | +45.86% |
| 5-year return | — | -96.48% |
| EPS (TTM) | $-0.22 | $-1.96 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $38.41 | $6.95 |
| 52-week low | $12.95 | $1.21 |
| Distance from 52-week high | -54.28% | -62.01% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +213.21% | +177.65% |
| Average volume | 187.66K | 1.21M |
| Shares outstanding | 14.86M | 98.12M |
| Employees | 4 | 106 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Vogenx
VOGX stock →Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Zentalis Pharmaceuticals
ZNTL stock →Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. It develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types.
Health Care · Biotechnology: Pharmaceutical Preparations · 106 employees
VOGX vs ZNTL FAQ
Which is bigger, Vogenx or Zentalis Pharmaceuticals?
Vogenx (VOGX) is larger, with a market capitalization of $260.86M compared with $259.04M for Zentalis Pharmaceuticals (ZNTL).
Are Vogenx and Zentalis Pharmaceuticals in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.